GC Therapeutics
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- gc-tx.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series ASep 2024
- Rounds
- 1
About
GC Therapeutics (GCTx) is a Cambridge, MA-based biopharmaceutical company using synthetic biology and its proprietary TFome iPSC programming platform to convert patient-derived stem cells into therapeutic cell types with best-in-class efficiency. Founded by scientists from George Church's lab at Harvard, GCTx is developing allogeneic cell therapies for gastrointestinal, neurological, and immunological diseases.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sep 2024
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...